Financial statements Neomedic
Cash flow statement of Neomedic
Company age:
Age:
9 y. 13 d.
Share capital:
Share capital:
185 000 PLN
Cash inflows of NEOMEDIC
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -3 244 891,63 | -3 865 983,74 | -2 520 574,55 | -2 455 467,33 | -2 631 431,32 | -3 221 551,98 |
| Net cash flow from investing activities | -632 171,40 | -25 731 136,57 | 4 578 755,20 | 4 594 940,51 | 4 164 397,55 | 20 043 231,76 |
| Net cash flow from financial activities | 3 504 077,93 | 29 491 635,03 | -2 060 246,81 | -2 126 979,11 | -1 532 221,76 | -16 819 296,45 |
| Total net cash flow | -372 985,10 | -105 485,28 | -2 066,16 | 12 494,07 | 744,47 | 2 383,33 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.